Literature DB >> 2813556

Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains.

J K Belknap1, B Noordewier, M Lamé.   

Abstract

The pattern of sensitivity of mice from three inbred strains were compared on measures of morphine-induced analgesia (hot plate), locomotor activity, hypothermia, Straub tail (muscular rigidity), antidiuresis and constipation. The DBA/2J strain emerged as the most sensitive strain for analgesia, retention of a water load (antidiuresis) and hypothermia. In addition, the DBA/2J mice had lower concentrations of morphine in the brain 30 min after injection and had the lowest Kd and the highest Bmax for naloxone as measured by in vitro receptor binding. In contrast, mice of the C57BL/6J strain were most sensitive when locomotor activity, Straub tail and constipation were measured. The C3H/HeJ mice were generally intermediate in their sensitivity to morphine. The observed strain differences indicate a rather high degree of genetic control for most of the effects studied, however, the low consistency of rank order among the three strains across these measures suggests that the genetically determined mechanisms are largely different between these measures of morphine sensitivity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813556     DOI: 10.1016/0031-9384(89)90324-7

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  21 in total

1.  A pervasive mechanism for analgesia: activation of GIRK2 channels.

Authors:  Y A Blednov; M Stoffel; H Alva; R A Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-19       Impact factor: 11.205

2.  Inbred strain differences in morphine-induced analgesia with the hot plate assay: a reassessment.

Authors:  J K Belknap; M Lamé; P W Danielson
Journal:  Behav Genet       Date:  1990-03       Impact factor: 2.805

3.  Differential genetic risk for methamphetamine intake confers differential sensitivity to the temperature-altering effects of other addictive drugs.

Authors:  John R K Mootz; Nicholas B Miner; Tamara J Phillips
Journal:  Genes Brain Behav       Date:  2020-01-15       Impact factor: 3.449

4.  Individual differences in morphine and butorphanol analgesia: a laboratory pain study.

Authors:  Kimberly T Sibille; Lindsay L Kindler; Toni L Glover; Ricardo D Gonzalez; Roland Staud; Joseph L Riley; Roger B Fillingim
Journal:  Pain Med       Date:  2011-06-13       Impact factor: 3.750

5.  Opioid sensitivity in mice selectively bred to consume or not consume methamphetamine.

Authors:  Emily C Eastwood; Tamara J Phillips
Journal:  Addict Biol       Date:  2012-11-12       Impact factor: 4.280

6.  Strain differences in the rewarding and dopamine-releasing effects of morphine in rats.

Authors:  M Shoaib; R Spanagel; T Stohr; T S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

7.  Genetic differences in the rewarding and activating effects of morphine and ethanol.

Authors:  C L Cunningham; D R Niehus; D H Malott; L K Prather
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Tramadol and another atypical opioid meperidine have exaggerated serotonin syndrome behavioural effects, but decreased analgesic effects, in genetically deficient serotonin transporter (SERT) mice.

Authors:  Meredith A Fox; Catherine L Jensen; Dennis L Murphy
Journal:  Int J Neuropsychopharmacol       Date:  2009-03-11       Impact factor: 5.176

9.  Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds.

Authors:  Andras Bilkei-Gorzo; Ildiko Racz; Kerstin Michel; Anne Zimmer; Dietrich Klingmüller; Andreas Zimmer
Journal:  Psychopharmacology (Berl)       Date:  2004-06-09       Impact factor: 4.530

10.  Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice.

Authors:  Wojciech Solecki; Anna Turek; Jakub Kubik; Ryszard Przewlocki
Journal:  Psychopharmacology (Berl)       Date:  2009-09-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.